Valuation: AstraZeneca PLC

Market Cap 258B 226B 209B 192B 364B 24,912B 369B 2,498B 980B 12,186B 970B 949B 41,974B P/E 2026 *
21.2x
P/E 2027 * 18.6x
Enterprise Value 278B 243B 225B 207B 391B 26,763B 397B 2,684B 1,052B 13,092B 1,042B 1,019B 45,093B EV / Sales 2026 *
4.39x
EV / Sales 2027 * 4.05x
Free-Float
96.63%
Yield 2026 *
1.97%
Yield 2027 * 2.08%

Last Transcript: AstraZeneca PLC

1 day-1.70%
1 week-3.54%
Current month-12.20%
1 month-6.45%
3 months-18.11%
6 months-10.87%
Current year-10.22%
1 week 11,870
Extreme 11870
12,672
1 month 11,870
Extreme 11870
14,686
Current year 11,232
Extreme 11232
15,732
1 year 10,178
Extreme 10178
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Date Insider Type Main position Quantity % Market Cap.
7/6/26 Free

See Remarks

2 0.0000%
6/8/26 Free

See Remarks

1 0.0000%
5/20/26 Sell

See Remarks

-11,893 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.70%-3.54%+20.26%+17.88% 263B
-2.73%-3.51%+48.62%+152.87% 1,051B
-1.67%-3.18%+52.00%+56.75% 609B
-0.44%+2.14%+33.88%+84.04% 450B
-0.75%-1.46%+28.32%+22.33% 330B
-1.52%-0.95%+33.38%+38.39% 284B
-0.58%+1.78%-20.89%-38.37% 223B
-0.58%+0.21%+23.55%+56.94% 198B
-0.80%+2.60%+23.09%+68.71% 167B
-1.20%+2.40%+1.14%-32.08% 143B
Average -0.62%+0.85%+24.34%+42.74% 371.78B
Weighted average by Cap. -0.14%+0.16%+33.94%+71.44%

Financials

2026 *2027 *
Net sales 63.21B 55.41B 51.21B 47.09B 88.99B 6,096B 90.39B 611B 240B 2,982B 237B 232B 10,271B 66.79B 58.54B 54.11B 49.76B 94.03B 6,441B 95.5B 646B 253B 3,151B 251B 245B 10,852B
Net income 12.43B 10.9B 10.07B 9.26B 17.5B 1,199B 17.78B 120B 47.14B 586B 46.68B 45.66B 2,020B 13.94B 12.22B 11.29B 10.38B 19.62B 1,344B 19.93B 135B 52.85B 657B 52.33B 51.19B 2,265B
Net Debt 19.2B 16.82B 15.55B 14.3B 27.02B 1,851B 27.45B 186B 72.79B 906B 72.08B 70.5B 3,119B 11.9B 10.43B 9.64B 8.87B 16.76B 1,148B 17.02B 115B 45.14B 561B 44.69B 43.72B 1,934B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-07-20 GBX 12,380.00 -1.70% 1,718,923
26-07-17 GBX 12,594.00 -0.27% 2,012,949
26-07-16 GBX 12,628.00 +0.49% 1,602,666
26-07-15 GBX 12,566.00 +1.63% 3,346,169
26-07-14 GBX 12,364.00 -1.95% 3,313,274
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
166.14USD
Average target price
212.13USD
Spread / Average Target
+27.68%

Quarterly revenue - Rate of surprise